These regulatory dynamics highlight the central role of PI3K in modulating microglial functions and suggest its potential as a therapeutic target for controlling microglial overactivation in neurodegenerative diseases [1,99,100]. The gene discussed is PIK3CA; the disease is neurodegenerative disease.